A recent clinical trial suggests that taking a daily vitamin D supplement may help improve the effectiveness of chemotherapy in breast cancer patients.
Study details
The randomized trial included 80 women aged 45 and older who had been diagnosed with breast cancer and were scheduled to receive neoadjuvant chemotherapy, which is given before surgery to shrink tumors. The participants were randomly assigned to take either 2,000 IU of vitamin D daily or a placebo for six months, overlapping with their chemotherapy treatment.
Vitamin D is known for its role in bone health. It also affects the immune system and cellular processes that play a part in cancer growth. Breast tissue has vitamin D receptors. When those receptors are activated, they may slow tumor growth and help kill cancer cells.
Results
After finishing chemotherapy and surgery, 43 percent of women who took vitamin D showed a pathological complete response, meaning no cancer could be found in breast tissue. In the placebo group, only 24 percent reached that result. That is nearly double the rate of tumor elimination before surgery.
The researchers also measured vitamin D levels in the blood. Women with levels above 20 ng/mL were more than three times as likely to achieve a complete tumor response, regardless of other health factors. This finding suggests that even moderate vitamin D sufficiency may help chemotherapy work better.
How vitamin D may help
Vitamin D can affect genes that control cell growth, programmed cell death, and the spread of tumors. It may also make cancer cells more sensitive to chemotherapy drugs such as anthracyclines and taxanes, which are commonly used in breast cancer treatment. Earlier studies have found that vitamin D boosts the tumor-killing effect of those drugs.
Many breast cancer patients, especially those who have gone through menopause, have low vitamin D levels at the time of diagnosis. This deficiency might weaken their response to treatment. Chemotherapy itself can also lower vitamin D levels because patients may spend less time in the sun and because the drugs can affect how the body processes the vitamin. That is another reason why supplementing during treatment may be useful.
What this means
Taking a safe, low-cost supplement of 2,000 IU of vitamin D daily during chemotherapy could be a simple way to improve treatment results. The study was relatively small and took place at a single center, but its randomized design strengthens the evidence that vitamin D may help patients achieve better tumor control.
More research is needed to confirm the findings in larger and more diverse groups and to find the best dose. Because vitamin D is affordable and safe at recommended levels, it may be a practical addition to breast cancer care, especially for patients whose levels are low.
Maintaining adequate vitamin D levels could be a low-risk way to support more successful treatment outcomes. The study adds to a growing body of evidence linking nutrient status with cancer treatment success.
